Evoke Pharma Inc EFFECT, filed Dec 18, 2025: primary_doc.xml
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 |
| Accession Number: | 0001193125-25-322658 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||